Cite
HARVARD Citation
Puzzoni, M. et al. (n.d.). P-209P 53 abnormal expression might influence global outcome through EGFR modulation in RAS/BRAF wild type metastatic colorectal cancer patients receiving later-line irinotecan cetuximab. Annals of oncology. p. . [Online].